세계의 사이클로덱스트린 시장 : 유형별, 최종 사용자 산업별 기회 분석 및 산업 예측(2023-2032년)

Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 7,946,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,313,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계의 사이클로덱스트린(시클로덱스트린, Cyclodextrin) 시장은 2022년에 3억 3,400만 달러로 평가되어 2023년부터 2032년에 걸쳐 5.7%의 CAGR로 추이하며 성장 할 것으로 예상되며, 2032년에는 5억 7,960만 달러에 이를 것으로 추정되고 있습니다.

사이클로덱스트린은 알파-1,4-글리코시드 결합으로 연결된 포도당 단위로 구성된 고리형 올리고당입니다. 이 분자는 독특한 원환 또는 잘린 원뿔 구조를 가지고 있으며, 소수성 중앙 공동과 친수성 외부 표면이 특징입니다. 사이클로덱스트린은 다른 분자와 봉입 복합체를 형성하여 게스트 분자를 중앙 공동 내에 캡슐화할 수 있는 능력으로 잘 알려져 있습니다. 이러한 특성 덕분에 사이클로덱스트린은 제약, 식품, 화장품 등 다양한 산업에서 다양한 화합물의 용해도, 안정성 및 생체 이용률을 개선하는 등의 용도로 유용하게 사용됩니다.

지속 가능성 및 친환경 화학 관행에 대한 강조가 커지는 것도 사이클로덱스트린 시장의 또 다른 원동력입니다. 사이클로덱스트린은 생분해성이며 환경 친화적이기 때문에 친환경적인 대안이 우선시되는 응용 분야에 적합합니다. 기존 화학 물질 대신 사이클로덱스트린을 사용하는 것은 지속 가능한 관행을 향한 전 세계적인 추세에 부합하며, 환경을 고려한 솔루션을 찾는 업계에 매력적으로 다가옵니다.

또한 다양한 산업 분야에서 진행 중인 연구 개발 활동도 사이클로덱스트린 시장 확대에 기여하고 있습니다. 연구자들은 사이클로덱스트린의 고유한 특성을 활용하는 새로운 응용 분야와 제형을 모색하고 있습니다. 여기에는 새로운 약물 전달 시스템, 개선된 캡슐화 기술, 농업 및 섬유와 같은 분야에서의 혁신적인 용도가 포함됩니다. 새로운 응용 분야의 지속적인 발견과 독점적인 제형 개발은 사이클로덱스트린에 대한 수요를 주도하고 있습니다.

그러나 규제 고려 사항도 사이클로덱스트린 시장에 영향을 미칩니다. 사이클로덱스트린은 제약 및 식품을 비롯한 다양한 용도로 사용되기 때문에 엄격한 규제 요건을 준수하는 것이 중요합니다. 사이클로덱스트린 함유 제품에 대한 규제 승인을 획득하는 데는 많은 시간과 비용이 소요될 수 있습니다. 또한 진화하는 규제 환경과 규정 준수 표준의 변화로 인해 제조업체는 지속적인 적응이 필요할 수 있으며, 이는 시장에 복잡성을 더할 수 있습니다.

반대로 식음료 부문에서는 사이클로덱스트린이 캡슐화제, 향료 개량제, 안정제 등으로 활용되고 있습니다. 이러한 제품은 제품의 품질, 맛, 유통기한을 개선하는 데 기여합니다. 소비자들이 점점 더 건강하고 자연적인 재료를 찾게 되면서, 원치 않는 맛과 냄새를 가릴 수 있는 사이클로덱스트린은 식품 제조업체에게 매우 귀중한 존재가 되었습니다. 클린 라벨 제품에 대한 추세와 기능성 식품에 대한 수요는 이 시장 부문의 기회를 더욱 촉진하고 있습니다.

사이클로덱스트린 시장은 유형, 최종 사용자 산업 및 지역에 따라 분류됩니다. 유형별로 시장은 알파-사이클로덱스트린, 베타-사이클로덱스트린, 감마-사이클로덱스트린으로 분류됩니다. 최종 사용자 산업 기반은 식품, 의약품, 화장품 및 개인 관리, 화학, 섬유 및 기타로 나눌 수 있습니다. 지역별로 시장은 북미, 유럽, 아시아 태평양, LAMEA로 구분하여 조사했습니다.

이해관계자를 위한 주요 이점

• 본 보고서에서는 2022년부터 2032년까지의 사이클로덱스트린 시장 분석 시장 부문, 현재 동향, 추정·동향, 역학을 정량적으로 분석하여 유력한 사이클로덱스트린 시장 기회를 특정합니다.
• 시장 성장 촉진 요인, 시장 성장 억제 요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해관계자들이 이익에 중점을 둔 비즈니스 결정을 내리고 공급업체와 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 보여줍니다.
• 사이클로덱스트린 시장의 세분화에 대한 자세한 분석은 시장 기회를 결정하는 데 도움이 됩니다.
• 각 지역의 주요 국가를 세계 시장에 대한 매출 기여도에 따라 매핑합니다.
• 시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계 사이클로덱스트린 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략 분석이 포함되어 있습니다.

이 보고서에서 가능한 맞춤설정(추가 비용 및 일정 필요)

• 제조 역량
• 투자 기회
• 공급망 분석 및 벤더 마진
• 기술 동향 분석
• 제품/부문별 기업 시장 세분화 분석
• 주요 기업의 신제품 개발/제품 매트릭스
• 국가, 지역, 세계 수준의 고객/역학 데이터
• 규제 가이드라인
• 고객의 관심에 따른 추가 기업 개요
• 국가별 또는 지역별 추가 분석-시장 규모 및 예측
• 확장된 기업 개요 목록
• 과거 시장 데이터
• 수출입 분석/데이터
• 주요 기업의 상세(소재지, 연락처, 공급업체/벤더 네트워크 등을 포함한 엑셀 형식)
• 글로벌/지역/국가 수준에서 플레이어의 시장 점유율 분석
• SWOT 분석
• 수량 시장 규모 및 예측

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의 및 범위
• 주요 조사 결과
  • 영향 요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진 요인
  • 억제 요인
  • 기회
• 밸류체인 분석
• 가격 분석
• 주요 규제 분석
• 특허 상황

제4장 사이클로덱스트린 시장 : 유형별

• 개요
• α-사이클로덱스트린
• β-사이클로덱스트린
• γ-사이클로덱스트린

제5장 사이클로덱스트린 시장 : 최종 사용자 산업별

• 개요
• 식품
• 의약품
• 화장품 및 퍼스널케어
• 화학
• 섬유
• 기타

제6장 사이클로덱스트린 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 아시아 태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주
  • 기타
• 남미, 중동 및 아프리카(LAMEA)
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제7장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2022년)

제8장 기업 개요

• Cayman Chemical Company
• Cambrex Corporation
• Wellona Pharma Private Limited.
• Wacker Chemie AG.
• Cyclolab
• Tocopharm Co. Limited
• Roquette Freres
• Midas Pharma GmbH
• Ligand Pharmaceuticals Incorporated
• Cyclo Therapeutics, Inc

LYJ

영문 목차

영문목차

The global cyclodextrin market was valued at $334.0 million in 2022 and is estimated to reach $579.6 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.

Cyclodextrins are cyclic oligosaccharides composed of glucose units linked by alpha-1,4-glycosidic bonds. These molecules have a unique torus or truncated cone structure, characterized by a hydrophobic central cavity and a hydrophilic outer surface. Cyclodextrins are known for their ability to form inclusion complexes with other molecules, where the guest molecule can be encapsulated within their central cavity. This property makes cyclodextrins useful in various industries, including pharmaceuticals, food, cosmetics, and more, for applications such as improving the solubility, stability, and bioavailability of different compounds.

The growing emphasis on sustainability and green chemistry practices is another driving force for the cyclodextrin market. Cyclodextrins are biodegradable and environmentally friendly, making them attractive for applications where eco-friendly alternatives are prioritized. The use of cyclodextrins in place of traditional chemicals aligns with the global push towards sustainable practices, appealing to industries seeking environmentally conscious solutions.

Moreover, ongoing research and development activities in various industries contribute to the expansion of the cyclodextrin market. Researchers are exploring new applications and formulations that leverage the unique properties of cyclodextrins. This includes novel drug delivery systems, improved encapsulation techniques, and innovative uses in areas such as agriculture and textiles. The continuous discovery of novel applications and the development of proprietary formulations drive the demand for cyclodextrins.

However, regulatory considerations also impact the cyclodextrin market. As cyclodextrins are used in various applications, including pharmaceuticals and food products, adherence to stringent regulatory requirements is crucial. Obtaining regulatory approvals for cyclodextrin-containing products can be time-consuming and expensive. Additionally, evolving regulatory landscapes and changes in compliance standards may require continuous adaptation by manufacturers, adding a layer of complexity to the market.

On the contrary, in the food and beverage sector, cyclodextrins find applications as encapsulating agents, flavor modifiers, and stabilizers. They contribute to improved product quality, taste, and shelf life. As consumers increasingly seek healthier and more natural ingredients, cyclodextrins, with their ability to mask undesirable flavors and odors, become invaluable for food manufacturers. The trend towards clean-label products and the demand for functional foods further drive the opportunities in this market segment.

The cyclodextrin market is segmented on the basis of type, end-user industry, and region. On the basis of type, the market is categorized into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. On the basis of end-user industry, it is divided into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The global cyclodextrin market profiles leading players that include Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette Freres, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.

Other key players involved in the manufacturing of cyclodextrin includes Zibo Qianhui biological technology co., ltd, Xi'an Deli Biochemical Industry Co., Ltd, Merck KgaA, Otto Chemie Pvt. Ltd., VIO CHEMICALS, Ashland, and TCI Chemicals Pvt. Ltd. The global cyclodextrin market report provides in-depth competitive analysis as well as profiles of these major players.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cyclodextrin market analysis from 2022 to 2032 to identify the prevailing cyclodextrin market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cyclodextrin market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cyclodextrin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Manufacturing Capacity
• Investment Opportunities
• Supply Chain Analysis & Vendor Margins
• Technology Trend Analysis
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Patient/epidemiology data at country, region, global level
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Import Export Analysis/Data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• Market share analysis of players at global/region/country level
• SWOT Analysis
• Volume Market Size and Forecast

Key Market Segments

By Type

• Alpha-Cyclodextrin
• Beta-Cyclodextrin
• Gamma-Cyclodextrin

By End-User Industry

• Food
• Pharmaceutical
• Cosmetics and Personal Care
• Chemical
• Textile
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Cayman Chemical Company
• Cambrex Corporation
• Wellona Pharma Private Limited.
• Wacker Chemie AG.
• Cyclolab
• Tocopharm Co. Limited
• Roquette Freres
• Midas Pharma GmbH
• Ligand Pharmaceuticals Incorporated
• Cyclo Therapeutics, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities
• 3.5. Value Chain Analysis
• 3.6. Pricing Analysis
• 3.7. Key Regulation Analysis
• 3.8. Patent Landscape

CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Alpha-Cyclodextrin
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Beta-Cyclodextrin
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Gamma-Cyclodextrin
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Food
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Pharmaceutical
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Cosmetics and Personal Care
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Chemical
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Textile
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country
• 5.7. Others
  • 5.7.1. Key market trends, growth factors and opportunities
  • 5.7.2. Market size and forecast, by region
  • 5.7.3. Market share analysis by country

CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION

• 6.1. Overview
  • 6.1.1. Market size and forecast By Region
• 6.2. North America
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by Type
  • 6.2.3. Market size and forecast, by End-User Industry
  • 6.2.4. Market size and forecast, by country
    • 6.2.4.1. U.S.
    • 6.2.4.1.1. Market size and forecast, by Type
    • 6.2.4.1.2. Market size and forecast, by End-User Industry
    • 6.2.4.2. Canada
    • 6.2.4.2.1. Market size and forecast, by Type
    • 6.2.4.2.2. Market size and forecast, by End-User Industry
    • 6.2.4.3. Mexico
    • 6.2.4.3.1. Market size and forecast, by Type
    • 6.2.4.3.2. Market size and forecast, by End-User Industry
• 6.3. Europe
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by Type
  • 6.3.3. Market size and forecast, by End-User Industry
  • 6.3.4. Market size and forecast, by country
    • 6.3.4.1. Germany
    • 6.3.4.1.1. Market size and forecast, by Type
    • 6.3.4.1.2. Market size and forecast, by End-User Industry
    • 6.3.4.2. UK
    • 6.3.4.2.1. Market size and forecast, by Type
    • 6.3.4.2.2. Market size and forecast, by End-User Industry
    • 6.3.4.3. France
    • 6.3.4.3.1. Market size and forecast, by Type
    • 6.3.4.3.2. Market size and forecast, by End-User Industry
    • 6.3.4.4. Spain
    • 6.3.4.4.1. Market size and forecast, by Type
    • 6.3.4.4.2. Market size and forecast, by End-User Industry
    • 6.3.4.5. Italy
    • 6.3.4.5.1. Market size and forecast, by Type
    • 6.3.4.5.2. Market size and forecast, by End-User Industry
    • 6.3.4.6. Rest of Europe
    • 6.3.4.6.1. Market size and forecast, by Type
    • 6.3.4.6.2. Market size and forecast, by End-User Industry
• 6.4. Asia-Pacific
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by Type
  • 6.4.3. Market size and forecast, by End-User Industry
  • 6.4.4. Market size and forecast, by country
    • 6.4.4.1. China
    • 6.4.4.1.1. Market size and forecast, by Type
    • 6.4.4.1.2. Market size and forecast, by End-User Industry
    • 6.4.4.2. India
    • 6.4.4.2.1. Market size and forecast, by Type
    • 6.4.4.2.2. Market size and forecast, by End-User Industry
    • 6.4.4.3. Japan
    • 6.4.4.3.1. Market size and forecast, by Type
    • 6.4.4.3.2. Market size and forecast, by End-User Industry
    • 6.4.4.4. South Korea
    • 6.4.4.4.1. Market size and forecast, by Type
    • 6.4.4.4.2. Market size and forecast, by End-User Industry
    • 6.4.4.5. Australia
    • 6.4.4.5.1. Market size and forecast, by Type
    • 6.4.4.5.2. Market size and forecast, by End-User Industry
    • 6.4.4.6. Rest of Asia-Pacific
    • 6.4.4.6.1. Market size and forecast, by Type
    • 6.4.4.6.2. Market size and forecast, by End-User Industry
• 6.5. LAMEA
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by Type
  • 6.5.3. Market size and forecast, by End-User Industry
  • 6.5.4. Market size and forecast, by country
    • 6.5.4.1. Brazil
    • 6.5.4.1.1. Market size and forecast, by Type
    • 6.5.4.1.2. Market size and forecast, by End-User Industry
    • 6.5.4.2. Saudi Arabia
    • 6.5.4.2.1. Market size and forecast, by Type
    • 6.5.4.2.2. Market size and forecast, by End-User Industry
    • 6.5.4.3. South Africa
    • 6.5.4.3.1. Market size and forecast, by Type
    • 6.5.4.3.2. Market size and forecast, by End-User Industry
    • 6.5.4.4. Rest of LAMEA
    • 6.5.4.4.1. Market size and forecast, by Type
    • 6.5.4.4.2. Market size and forecast, by End-User Industry

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product mapping of top 10 player
• 7.4. Competitive dashboard
• 7.5. Competitive heatmap
• 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

• 8.1. Cayman Chemical Company
  • 8.1.1. Company overview
  • 8.1.2. Key executives
  • 8.1.3. Company snapshot
  • 8.1.4. Operating business segments
  • 8.1.5. Product portfolio
  • 8.1.6. Business performance
  • 8.1.7. Key strategic moves and developments
• 8.2. Cambrex Corporation
  • 8.2.1. Company overview
  • 8.2.2. Key executives
  • 8.2.3. Company snapshot
  • 8.2.4. Operating business segments
  • 8.2.5. Product portfolio
  • 8.2.6. Business performance
  • 8.2.7. Key strategic moves and developments
• 8.3. Wellona Pharma Private Limited.
  • 8.3.1. Company overview
  • 8.3.2. Key executives
  • 8.3.3. Company snapshot
  • 8.3.4. Operating business segments
  • 8.3.5. Product portfolio
  • 8.3.6. Business performance
  • 8.3.7. Key strategic moves and developments
• 8.4. Wacker Chemie AG.
  • 8.4.1. Company overview
  • 8.4.2. Key executives
  • 8.4.3. Company snapshot
  • 8.4.4. Operating business segments
  • 8.4.5. Product portfolio
  • 8.4.6. Business performance
  • 8.4.7. Key strategic moves and developments
• 8.5. Cyclolab
  • 8.5.1. Company overview
  • 8.5.2. Key executives
  • 8.5.3. Company snapshot
  • 8.5.4. Operating business segments
  • 8.5.5. Product portfolio
  • 8.5.6. Business performance
  • 8.5.7. Key strategic moves and developments
• 8.6. Tocopharm Co. Limited
  • 8.6.1. Company overview
  • 8.6.2. Key executives
  • 8.6.3. Company snapshot
  • 8.6.4. Operating business segments
  • 8.6.5. Product portfolio
  • 8.6.6. Business performance
  • 8.6.7. Key strategic moves and developments
• 8.7. Roquette Freres
  • 8.7.1. Company overview
  • 8.7.2. Key executives
  • 8.7.3. Company snapshot
  • 8.7.4. Operating business segments
  • 8.7.5. Product portfolio
  • 8.7.6. Business performance
  • 8.7.7. Key strategic moves and developments
• 8.8. Midas Pharma GmbH
  • 8.8.1. Company overview
  • 8.8.2. Key executives
  • 8.8.3. Company snapshot
  • 8.8.4. Operating business segments
  • 8.8.5. Product portfolio
  • 8.8.6. Business performance
  • 8.8.7. Key strategic moves and developments
• 8.9. Ligand Pharmaceuticals Incorporated
  • 8.9.1. Company overview
  • 8.9.2. Key executives
  • 8.9.3. Company snapshot
  • 8.9.4. Operating business segments
  • 8.9.5. Product portfolio
  • 8.9.6. Business performance
  • 8.9.7. Key strategic moves and developments
• 8.10. Cyclo Therapeutics, Inc
  • 8.10.1. Company overview
  • 8.10.2. Key executives
  • 8.10.3. Company snapshot
  • 8.10.4. Operating business segments
  • 8.10.5. Product portfolio
  • 8.10.6. Business performance
  • 8.10.7. Key strategic moves and developments

관련자료